NASDAQ:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis $1.96 -0.02 (-1.01%) Closing price 09/8/2026 04:00 PM EasternExtended Trading$2.00 +0.04 (+1.99%) As of 09/8/2026 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC Filings About IM Cannabis Stock (NASDAQ:IMCC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IM Cannabis alerts:Sign Up Key Stats Today's Range$1.85▼$2.0150-Day Range$1.96▼$4.8352-Week Range$1.85▼$77.10Volume29,724 shsAverage Volume119,932 shsMarket Capitalization$411.60 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview IM Cannabis Corp is a vertically integrated medical cannabis company based in Israel, specializing in the research, cultivation and production of cannabis-based formulations. The company holds three key licenses granted by the Israeli Ministry of Health, covering cultivation, possession and distribution of medical-grade cannabis. Its production facilities in Moshav Yizrael feature controlled-environment agriculture chambers designed to deliver consistent, high-purity cannabinoid profiles. The company’s product portfolio includes standardized cannabis oils, distillates, vaporizer cartridges and topical preparations, all formulated under Good Manufacturing Practice (GMP) standards. IM Cannabis invests in ongoing scientific research and development to advance proprietary extraction techniques and novel dosage forms, with an emphasis on patient safety, reproducibility and therapeutic efficacy. These efforts support both internal clinical initiatives and potential collaborations with academic and pharmaceutical partners. Since its founding in 2018, IM Cannabis has pursued domestic and international market expansion through supply agreements and export licenses. The company serves Israel’s growing medical cannabis patient base and has secured partnerships to facilitate exports to regulated markets, including Europe and Australia. IM Cannabis is led by an experienced management team with backgrounds in pharmaceutical development, agriculture technology and regulatory affairs, and trades on the Nasdaq Capital Market under the ticker IMCC.AI Generated. May Contain Errors. Read More IM Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks4th Percentile Overall ScoreIMCC MarketRank™: IM Cannabis scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingIM Cannabis has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageIM Cannabis has only been the subject of 1 research reports in the past 90 days.Read more about IM Cannabis' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of IM Cannabis is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IM Cannabis is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about IM Cannabis' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.05% of the float of IM Cannabis has been sold short.Short Interest Ratio / Days to CoverIM Cannabis has a short interest ratio ("days to cover") of 0.52, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IM Cannabis has recently decreased by 20.58%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIM Cannabis does not currently pay a dividend.Dividend GrowthIM Cannabis does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for IM Cannabis this week, compared to 1 article on an average week. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, IM Cannabis insiders have not sold or bought any company stock.Percentage Held by Institutions7.68% of the stock of IM Cannabis is held by institutions.Read more about IM Cannabis' insider trading history. Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMCC Stock News HeadlinesIM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note FinancingSeptember 2, 2026 | prnewswire.comIM Cannabis Shares Commence Trading on 30:1 Consolidated BasisAugust 27, 2026 | prnewswire.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it. | Banyan Hill Publishing (Ad)IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price ComplianceAugust 18, 2026 | prnewswire.comIM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused AssetsAugust 17, 2026 | prnewswire.comIM Cannabis Corp. Announces Second Quarter and First Half 2026 Financial ResultsAugust 13, 2026 | prnewswire.comIM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note FinancingAugust 7, 2026 | prnewswire.comIM Cannabis Provides Corporate UpdateJuly 27, 2026 | prnewswire.comSee More Headlines IMCC Stock Analysis - Frequently Asked Questions How have IMCC shares performed this year? IM Cannabis' stock was trading at $41.70 on January 1st, 2026. Since then, IMCC shares have decreased by 95.3% and is now trading at $1.96. How were IM Cannabis' earnings last quarter? IM Cannabis Corp. (NASDAQ:IMCC) posted its quarterly earnings results on Thursday, August, 13th. The company reported ($0.34) earnings per share (EPS) for the quarter. The firm had revenue of $5.34 million for the quarter. IM Cannabis had a negative net margin of 39.62% and a negative trailing twelve-month return on equity of 585.96%. When did IM Cannabis' stock split? IM Cannabis shares reverse split on Friday, July 12th 2024.The 1-6 reverse split was announced on Friday, July 12th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IM Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that IM Cannabis investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), GE Aerospace (GE) and AppLovin (APP). Company Calendar Last Earnings8/13/2026Today9/09/2026Next Earnings (Estimated)11/16/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (9m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 IMCC's financial health is in the Red zone, according to TradeSmith. IMCC has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:IMCC CIK1792030 Webwww.imcannabis.com Phone972-54-433-1111FaxN/AEmployees340Year FoundedN/AProfitability EPS (Trailing Twelve Months)($60.66) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$8.10 million Net Margins-39.62% Pretax Margin-40.21% Return on Equity-585.96% Return on Assets-58.32% Debt Debt-to-Equity RatioN/A Current Ratio0.56 Quick Ratio0.46 Sales & Book Value Annual Sales$39.17 million Price / Sales0.01 Cash FlowN/A Price / Cash FlowN/A Book Value($14.81) per share Price / Book-0.13Miscellaneous Outstanding Shares210,000Free FloatN/AMarket Cap$411.60 thousand OptionableNot Optionable Beta2.10 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:IMCC) was last updated on 9/9/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share IM Cannabis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
